CareLoop NICE EVA Recommendation

NICE EVA Article banner image

25 March 2024

Following a public consultation, the National Institute for Health and Care Excellence (NICE) has today published its final recommendation for digital health technologies to help manage symptoms of psychosis and prevent relapse in adults and young people.  The recommendation includes the use of CareLoop for monitoring symptoms of psychosis to prevent relapse.

CareLoop Health’s digital therapeutic is one of three technologies recommended for use in the NHS while more evidence is generated.  Technologies are selected for the EVA programme, in consultation with NHS England, on the basis that they have the potential to address national unmet need in priority areas. 

Looking at the prospective system benefits of the technology, NICE concluded ‘CareLoop may enable earlier treatment, which could reduce hospitalisations and demand on crisis intervention services

Commenting on the guidance, Prof Shôn Lewis, Chief Medical Officer, and co-founder of CareLoop said “In trials using CareLoop alongside standard care resulted in 50% fewer relapse events with patients telling us it was helpful in understanding and managing their symptoms.  The EVA is the next step along our journey to demonstrate the efficacy of CareLoop in the treatment of psychosis and schizophrenia”.

“Our focus as a business is to drive the adoption of CareLoop here in the UK and internationally”, adds Zoë Blake, CEO at CareLoop. “NICE is a recognised quality standard across the world.  Going through the EVA gives healthcare providers the confidence that CareLoop has been through rigorous evaluation and is ready for early adopter roll-out.”

Further real-world evidence will be generated across a period of up to 3 years.  After this time NICE will review the evidence gathered and assess if the technologies can be routinely adopted in the NHS. Care for people living with severe mental illness (SMI) hasn’t changed significantly for decades, our aim is to transform care using digital technology to support service user participation and to prevent escalation by predicting personalised early warning signs for timely intervention.

Read more about NICE EVA guidance on their website